Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV Vaccination Schemes in Cirrhotic Patients Awaiting Transplant
NCT01884415Phase 3Completed
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Sep 2012
- Primary completion
- Dec 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Recombivax HB in hepatitis B (HBV) (2 arms), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Primary endpoint: Post-vaccination serological response. Started Sep 2012; status: completed.
02
Drugs
Recombivax HB
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01884415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01884415.